FMS - Outset Medical Looks Like A Good Short Ahead Of IPO Unlock
- Outset Medical's IPO unlock happens on 3/15, where 27.3 million more shares become available for sale, roughly twice the current float.
- Revenue expectations for the Q4 quarter may be too high and could show negative sequential growth.
- Despite a reasonable $35 million/year run rate, gross margin is still deeply in the red at -41%.
- Snowflake and Affirm have been weak since their unlock dates, and the same may happen to Outset.
For further details see:
Outset Medical Looks Like A Good Short Ahead Of IPO Unlock